Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors

Documenti analoghi

• The novel thromboxane prostanoid receptor mediates CTGF production to drive human nasal fibroblast self‐migration through NF‐κB and PKCδ‐CREB signaling pathways
  di: Shih‐Lun Chang, et al.
  Pubblicazione: (2024)
• Platelet aggregation response to cyclooxygenase inhibition and thromboxane receptor antagonism using impedance aggregometry: A pilot study
  di: Auni C. Williams, et al.
  Pubblicazione: (2024)
• Photonics outlook for 2025: Illuminating the path to innovation
  di: Shahida Imani
  Pubblicazione: (2025)
• A Deep Reinforcement Learning based Scheduler for IoT Devices in Co-existence with 5G-NR
  di: Jabeen, Shahida
  Pubblicazione: (2025)
• Synthesis of 1‐Azabicyclo[2.1.1]hexanes via Formal Single Electron Reduction of Azabicyclo[1.1.0]butanes under Photochemical Conditions
  di: Margherita Zanini, et al.
  Pubblicazione: (2024)